Alchemab Therapeutics

Drug Discovery · London, United Kingdom · Founded 2019 · Privately Held (backing)

Developer of natural protective antibodies designed to keep people free of hard-to-treat diseases in a transformative approach. Alchemab Therapeutics is based in London, United Kingdom and was founded in 2019. It was valued at $138 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $32.1 million across 1 recorded round; the latest was a $31.9 million Series A in Sep 2025.

PMV mark · valuation
$138.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$32.1M
Last round
Later Stage VC (Series A)
Sep 2025
How much has Alchemab Therapeutics raised?
$32.1Macross 1 recorded rounds · Sep 2025 – Sep 2025

Most recently, Alchemab Therapeutics raised $31.9M in its Later Stage VC (Series A) (Sep 2025).

Free account
More of Alchemab Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Alchemab Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Alchemab Therapeutics round by round

1 rounds
Sep 2025Later Stage VC (Series A)$31.9M▮
+ 1 more investors · free account

How much has Alchemab Therapeutics raised?

Alchemab Therapeutics has raised $32.1 million across 1 recorded round since 2025. The largest was a $31.9 million Series A in Sep 2025.

Alchemab Therapeutics investors

11 investors are on record for Alchemab Therapeutics, including Innovate UK, RA Capital Management, DCVC and SV Health Investors. By type, the record holds 6 venture capital firms and 1 asset manager. The Series A in Sep 2025 drew 6 investors.

For fundraisers
Raising for a company like Alchemab Therapeutics?

11 investors have backed Alchemab Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 11 investors →

Frequently asked about Alchemab Therapeutics

How much has Alchemab Therapeutics raised?
Alchemab Therapeutics has raised $32.1M in total across 1 recorded funding rounds.
When was Alchemab Therapeutics's last funding round?
Alchemab Therapeutics's most recent recorded round was Later Stage VC (Series A) in Sep 2025, raising $31.9M.